Business Description
Lepu Biopharma Co Ltd
ISIN : CNE100004SM4
Share Class Description:
HKSE:02157: Class HCompare
Compare
Traded in other countries / regions
02157.Hong Kong IPO Date
2022-02-23Description
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.75 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.85 | |||||
| Debt-to-EBITDA | -11.36 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.56 | |||||
| Beneish M-Score | 9.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 28.1 | |||||
| 3-Year FCF Growth Rate | 28.4 | |||||
| 3-Year Book Growth Rate | -17.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 55.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.83 | |||||
| 9-Day RSI | 41.76 | |||||
| 14-Day RSI | 45.76 | |||||
| 6-1 Month Momentum % | -33.48 | |||||
| 12-1 Month Momentum % | -19.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | |||||
| Quick Ratio | 0.73 | |||||
| Cash Ratio | 0.59 | |||||
| Days Inventory | 213.9 | |||||
| Days Sales Outstanding | 57.58 | |||||
| Days Payable | 1711.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.55 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.7 | |||||
| Operating Margin % | -209.17 | |||||
| Net Margin % | -34.28 | |||||
| FCF Margin % | -163.11 | |||||
| ROE % | -8.16 | |||||
| ROA % | -2.9 | |||||
| ROIC % | -19.51 | |||||
| ROC (Joel Greenblatt) % | -6.76 | |||||
| ROCE % | -4.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 23.15 | |||||
| PB Ratio | 5.31 | |||||
| Price-to-Tangible-Book | 12.83 | |||||
| EV-to-EBIT | -75.36 | |||||
| EV-to-EBITDA | -75.36 | |||||
| EV-to-Revenue | 24.94 | |||||
| EV-to-FCF | -15.52 | |||||
| Earnings Yield (Greenblatt) % | -1.33 | |||||
| FCF Yield % | -6.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lepu Biopharma Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 222.017 | ||
| EPS (TTM) (HK$) | -0.041 | ||
| Beta | 0 | ||
| Volatility % | 108.4 | ||
| 14-Day RSI | 45.76 | ||
| 14-Day ATR (HK$) | 0.311783 | ||
| 20-Day SMA (HK$) | 3.435 | ||
| 12-1 Month Momentum % | -19.47 | ||
| 52-Week Range (HK$) | 2.16 - 6.5 | ||
| Shares Outstanding (Mil) | 1,710.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lepu Biopharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lepu Biopharma Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lepu Biopharma Co Ltd Frequently Asked Questions
What is Lepu Biopharma Co Ltd(HKSE:02157)'s stock price today?
The current price of HKSE:02157 is HK$3.08. The 52 week high of HKSE:02157 is HK$6.50 and 52 week low is HK$2.16.
When is next earnings date of Lepu Biopharma Co Ltd(HKSE:02157)?
The next earnings date of Lepu Biopharma Co Ltd(HKSE:02157) is .
Does Lepu Biopharma Co Ltd(HKSE:02157) pay dividends? If so, how much?
Lepu Biopharma Co Ltd(HKSE:02157) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers